ASH
ASHLAND INC.
+0.90 (+1.28%)71.38USD100.0K成交股數3.3B市值56.6本益比(近四季)1.8股價營收比+7.3%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 9 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 497M+4% | 482M+19% | 386M-26% | 463M-15% | 479M-17% | 405M-14% | 521M-5% | 544M-10% | 575M | 473M | 546M | 603M |
| 營業成本 | 327M | 335M | 281M | 331M | 332M | 294M | 348M | 358M | 414M | 375M | 368M | 406M |
| 毛利 | 170M+16% | 147M+32% | 105M-39% | 132M-29% | 147M-9% | 111M+13% | 173M-3% | 186M-6% | 161M | 98.0M | 178M | 197M |
| 毛利率 | 34.2% | 30.5% | 27.2% | 28.5% | 30.7% | 27.4% | 33.2% | 34.2% | 28.0% | 20.7% | 32.6% | 32.7% |
| 研發費用 | 15.0M | 14.0M | 13.0M | 13.0M | 14.0M | 13.0M | 14.0M | 15.0M | 14.0M | 12.0M | 12.0M | 12.0M |
| 銷售管理費用 | 99.0M | 79.0M | 86.0M | 106M | 85.0M | 78.0M | 101M | 114M | 106M | 83.0M | 84.0M | 79.0M |
| 營業利益 | 43.0M-16% | 39.0M-122% | −6.0M-119% | −708M+1061% | 51.0M+143% | −179M+894% | 32.0M-48% | −61.0M-173% | 21.0M | −18.0M | 62.0M | 83.0M |
| 營業利益率 | 8.7% | 8.1% | -1.6% | -152.9% | 10.6% | -44.2% | 6.1% | -11.2% | 3.7% | -3.8% | 11.4% | 13.8% |
| 稅後淨利 | 16.0M-48% | 16.0M-110% | −12.0M-171% | −742M-12467% | 31.0M-74% | −165M-735% | 17.0M-66% | 6.0M-93% | 120M | 26.0M | 50.0M | 91.0M |
| 淨利率 | 3.2% | 3.3% | -3.1% | -160.3% | 6.5% | -40.7% | 3.3% | 1.1% | 20.9% | 5.5% | 9.2% | 15.1% |
| 稀釋 EPS | 0.35-46% | 0.34-110% | -0.26-176% | -16.21-13608% | 0.65-73% | -3.50-786% | 0.34-64% | 0.12-93% | 2.39 | 0.51 | 0.94 | 1.67 |
| 稀釋股數 | 46 | 46 | 46 | 46 | 47 | 47 | 50.0M | 51.0M | 51.0M | 51.0M | 53.0M | 55.0M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 440M | 343M | 304M | 207M | 168M | 219M | 300M | 399M | 439M | 440M | 349M | 399M |
| 應收帳款 | 256M | 244M | 190M | 201M | 226M | 163M | 243M | 224M | 260M | 194M | 345M | 395M |
| 存貨 | 490M | 506M | 565M | 567M | 542M | 528M | 545M | 532M | 550M | 588M | 712M | 730M |
| 總資產 | 4.6B | 4.5B | 4.5B | 4.6B | 5.2B | 5.2B | 5.6B | 5.7B | 5.9B | 5.9B | 6.0B | 6.2B |
| 有息負債 | 1.4B | 1.4B | 1.4B | 1.4B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 1.9B | 1.9B | 1.9B | 1.9B | 2.6B | 2.6B | 2.9B | 3.0B | 3.1B | 3.1B | 3.1B | 3.3B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −934M | −1.0B | −1.1B | −1.2B | −1.2B | −1.1B | −1.0B | −926M | −889M | −901M | −979M | −929M |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | 125M | – | – | −30.0M-115% | – | – | – | 201M | – | – |
| 資本支出 | – | – | 14.0M | – | – | 23.0M | – | – | – | 36.0M | – | – |
| 自由現金流 | – | – | 111M | – | – | −53.0M-132% | – | – | – | 165M | – | – |
| 折舊攤銷 | – | – | 48.0M | – | – | 51.0M | – | – | – | 77.0M | – | – |
| 買回庫藏股 | – | – | – | – | – | 0.00 | – | – | – | 100M | – | – |
| 現金股利 | – | – | 19.0M | – | – | 19.0M | – | – | – | 20.0M | – | – |
| 自由現金流率 | – | – | 28.8% | – | – | -13.1% | – | – | – | 34.9% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.9B
| Personal Care | 577M | 29.8% | -9.0% |
|---|---|---|---|
| Personal Care And Household | 577M | 29.8% | -9.0% |
| Specialty Additives | 511M | 26.4% | -10.7% |
| Intermediates | 137M | 7.1% | -4.9% |
| Intermediates And Solvents | 137M | 7.1% | -4.9% |
| Life Sciences 小計 | 641M | 33.1% | -20.9% |
地區2025 年度 · 1.8B
| 美國以外 | 1.4B | 74.6% | -8.7% |
|---|---|---|---|
| 美國 | 464M | 25.4% | -25.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.8B | -13.7% | −845M | -46.3% | -18.23 | 36.0M |
| FY2024 | 2.1B | -3.6% | 169M | 8.0% | 3.36 | 325M |
| FY2023 | 2.2B | -8.4% | 178M | 8.1% | 3.31 | 124M |
| FY2022 | 2.4B | +13.3% | 927M | 38.8% | 16.41 | 80.0M |
| FY2021 | 2.1B | +4.7% | 220M | 10.4% | 3.59 | 361M |
| FY2020 | 2.0B | -6.1% | −508M | -25.2% | -8.39 | 94.0M |
| FY2019 | 2.1B | -17.0% | 505M | 23.5% | 8.15 | −7.0M |
| FY2018 | 2.6B | – | 114M | 4.4% | 1.79 | 84.0M |